My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Population Health and Prevention cancel Social and Behavioral Health cancel Rhode Island cancel Ohio cancel

ASTHO Policy Watch 2022: Mental Health

Blog,
Health Policy Update,
Health Equity,
At-Risk Populations,
Rural Health,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
Suicide Prevention,
Policy,
State Health Policy,
Alabama,
Arizona,
Arkansas,
Colorado,
Delaware,
Florida,
Hawaii,
Illinois,
Indiana,
Kentucky,
Maine,
Maryland,
Minnesota,
New Jersey,
Ohio,
Oregon,
Rhode Island,
South Carolina,
Tennessee,
Texas,
Virginia,
Washington,
Washington, D.C.,
West Virginia,
Maggie Davis,
LGBTQ+

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

Innovations in Overdose Response: Strategies Implemented by Emergency Medical Services Providers

Report,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Opioids,
Overdose Prevention,
Data Modernization and Informatics,
Preparedness,
Maryland,
Ohio,
Rhode Island,
Tennessee,
Washington,
Leadership and Workforce Development,
Public Health Workforce

Initial estimates from 2020 suggest that annual drug overdose deaths in the United States reached a record high of 93,000. Fortunately EMS strategies are being put in place to combat this nation-wide issue.

Addressing Privacy Concerns of Using Mental Healthcare via Telehealth

Blog,
Health Policy Update,
Policy,
State Health Policy,
Public Health Law,
Population Health and Prevention,
Healthcare Access,
Telehealth,
Social and Behavioral Health,
Mental Health,
Public Health Infrastructure and Systems Improvement,
Alabama,
Arkansas,
Colorado,
Connecticut,
Georgia,
Idaho,
Illinois,
Kansas,
Kentucky,
Maryland,
Massachusetts,
Michigan,
Missouri,
Nebraska,
Nevada,
New Hampshire,
New York,
North Carolina,
Northern Mariana Islands,
Ohio,
Oklahoma,
Rhode Island,
South Carolina,
Tennessee,
Utah,
Virginia,
Evan Han,
Maggie Davis

In an effort to help meet demand, some states and territories have joined interjurisdictional licensing compacts that allow a mental healthcare provider licensed in one state to provide care in another state—without needing to gain ...

State/Territorial Policy Considerations for Preventing Adverse Childhood Experiences

Report,
Policy,
State Health Policy,
Population Health and Prevention,
Women, Infant, and Family Health,
ACEs,
Health Equity,
At-Risk Populations,
Social Determinants of Health,
Social and Behavioral Health,
Injury and Violence Prevention,
Alaska,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Florida,
Hawaii,
Idaho,
Illinois,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Dakota,
Ohio,
Oregon,
Rhode Island,
Tennessee,
Texas,
Vermont,
Virginia,
Washington,
Washington, D.C.,
Youth Mental Health,
LGBTQ+,
Firearm Injury and Violence Prevention

ASTHO staff identified a range of evidence-supported policies considered by state legislatures that could prevent ACEs. This report synthesizes these research and policy proposals and is intended for public health practitioners and ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...